Star Scientific Inc. (Nasdaq: CIGX) entered a research agreement with Roskamp Institute to develop a compound with the potential to treat Alzheimer's disease but the stock price dropped 47 cents to close at $2.48.
Star Scientific Enters Research Agreement
April 07, 2010 at 18:30 PM EDT
